Variant report
Variant | esv1792471 |
---|---|
Chromosome Location | chr5:45191744-45193745 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:45189744..45191464-chr5:45191625..45193258,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543792754 | chr5:45191799-45191800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs147573273 | chr5:45191814-45191815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs574228143 | chr5:45191831-45191832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs141961733 | chr5:45191847-45191848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs561949143 | chr5:45191857-45191858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192944219 | chr5:45191861-45191862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183535671 | chr5:45191862-45191863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs188026902 | chr5:45191888-45191889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563990134 | chr5:45191891-45191892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs527901494 | chr5:45191918-45191919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs145724492 | chr5:45191932-45191933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549405855 | chr5:45191947-45191948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs192509172 | chr5:45191955-45191956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538428323 | chr5:45192008-45192009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs548790009 | chr5:45192042-45192043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148223978 | chr5:45192049-45192050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534878960 | chr5:45192057-45192058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183944648 | chr5:45192074-45192075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558431842 | chr5:45192078-45192079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs571932565 | chr5:45192103-45192104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs537733918 | chr5:45192110-45192111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs188324794 | chr5:45192195-45192196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs13164730 | chr5:45192209-45192210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566412661 | chr5:45192237-45192238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs369580960 | chr5:45192272-45192273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs62367470 | chr5:45192276-45192277 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs369389834 | chr5:45192314-45192315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs543120642 | chr5:45192356-45192357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115380899 | chr5:45192379-45192380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140164794 | chr5:45192413-45192414 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540825398 | chr5:45192432-45192433 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs150356725 | chr5:45192460-45192461 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533103238 | chr5:45192482-45192483 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs543289266 | chr5:45192536-45192537 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs372967422 | chr5:45192554-45192555 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562976572 | chr5:45192589-45192590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs368502959 | chr5:45192606-45192607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs138024988 | chr5:45192627-45192628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542361999 | chr5:45192676-45192677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs114338967 | chr5:45192700-45192701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs557429855 | chr5:45192724-45192725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191244678 | chr5:45192797-45192798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565593024 | chr5:45192825-45192826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs116451824 | chr5:45192828-45192829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs184870215 | chr5:45192851-45192852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571869604 | chr5:45192874-45192875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs111800202 | chr5:45192892-45192893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537770926 | chr5:45192910-45192911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557673234 | chr5:45192935-45192936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs567683668 | chr5:45192992-45192993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Intellectual disability | 21811512 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:45182400-45192400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
2 | chr5:45184400-45192600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
3 | chr5:45192400-45193200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr5:45192400-45193400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr5:45192400-45193400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr5:45192600-45193400 | Enhancers | HUES64 Cell Line | embryonic stem cell |